Background Increasing evidence suggests that cerebral vascular dysfunction is associated
with the early stages of Alzheimer's disease (AD). Vascular endothelial growth factor (VEGF) …

Background Vascular endothelial growth factor (VEGF) and platelets seem to reflect the
Alzheimer's disease (AD) associated either with vascular impairment or disease. This study …

Objective–As vascular endothelial growth factor (VEGF) determines important neurotrophic
and neuroprotective actions, we postulated serum VEGF levels could be abnormally low in …

Vascular endothelial growth factor (VEGF) is an angioneurin involved in the regulation of
vascular and neural functions relevant for the pathophysiology of Alzheimer's disease (AD) …

Although the enhanced expression of vascular endothelial growth factor (VEGF) in the
brains of patients with Alzheimer's disease (AD) has been reported, the functional …

Fifteen Alzheimer (AD) and fifteen normative (NM) age-matched autopsy brains were
analyzed in superior temporal cortex, hippocampal and brainstem samples. Vascular …

Alzheimer's disease (AD) is accompanied by the progressive deposition of β-amyloid (Aβ) in
both senile plaques and cerebral blood vessels, loss of central neurons, and vessel …

Background and purpose The association between the presence of cerebral microbleeds
(CMBs) and serum vascular endothelial growth factor (VEGF) levels in patients with …

Alzheimer's disease (AD) is a common disorder of progressive cognitive decline among
elderly subjects. Angiogenesis-related factors including vascular endothelial growth factor …

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. Despite
upregulation of VEGF in the brain in Alzheimer's disease (AD), probably in response to …